Page last updated: 2024-11-06

prednisolone and Morbid Obesity

prednisolone has been researched along with Morbid Obesity in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Non-alcoholic fatty liver disease (NAFLD) is nowadays the most common liver disease worldwide."1.56Non-alcoholic steatohepatitis or autoimmune hepatitis? Sometimes a closer look under the surface is needed. ( Dalekos, GN; Gatselis, NK; Koukoulis, GK, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dalekos, GN1
Gatselis, NK1
Koukoulis, GK1

Other Studies

1 other study available for prednisolone and Morbid Obesity

ArticleYear
Non-alcoholic steatohepatitis or autoimmune hepatitis? Sometimes a closer look under the surface is needed.
    BMJ case reports, 2020, Dec-21, Volume: 13, Issue:12

    Topics: Adult; Antibodies, Antinuclear; Biopsy; Diagnosis, Differential; Diagnostic Errors; Elasticity Imagi

2020